About
Tom van Meerten is Professor of Onco-Immunology at the University Medical Center Groningen. His research focuses on developing immunotherapies for hematological cancers, particularly CAR T-cell treatments for lymphomas.
Van Meerten leads clinical trials investigating treatments like brexucabtagene autoleucel for mantle cell lymphoma and explores PET imaging biomarkers for immunotherapy. His team recently secured €16.5 million in funding for CAR T-cell research in bone marrow cancer.
0Publications listed
Find Tom van Meerten elsewhere
Related Searches
You Might Also Like
Mehrdad AbediUniversity of California, Davis · Professor
Luhua WangThe University of Texas MD Anderson Cancer Center · Professor- GGustaaf van ImhoffUniversity of Groningen · Researcher
Bryon D. JohnsonMedical College of Wisconsin · Professor- FFrancis Ayuketang AyukUniversity Medical Center Hamburg-Eppendorf · Researcher
Jonathan S. SerodyUniversity of North Carolina at Chapel Hill · Professor